Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Jay Barth currently holds 163,204 shares of AMICUS THERAPEUTICS INC (FOLD), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Jay Barth has been a net seller of FOLD stock. They have purchased $0 and sold $9.8M worth of shares.
Jay Barth's most recent insider trade was on Sep 30, 2020, when they sold 4,064 shares at $14.51 per share.
Jay Barth serves as Executive at AMICUS THERAPEUTICS INC (FOLD). They have executed 78 insider transactions totaling $9.8M over their tenure at the company.
Jay Barth holds the position of Executive at AMICUS THERAPEUTICS INC, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 12 years and currently hold a stake valued at $0.
Jay Barth has shown a selling trading pattern, with $0 in total purchases and $9.8M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Jay Barth was on Jul 7, 2020, when they sold $2.8M worth of FOLD shares. This transaction involved 178,988 shares at $15.90 per share.
Jay Barth currently owns 163,204 shares of AMICUS THERAPEUTICS INC (FOLD), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Jay Barth's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Jay Barth has 78 Form 4 filings on record as an insider at AMICUS THERAPEUTICS INC.
Set alerts for Jay Barth and 40,000+ other insiders.